UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prostate Age Gap: An MRI Surrogate Marker of Aging for Prostate Cancer Detection

Journal of magnetic resonance imaging, 2024-08, Vol.60 (2), p.458-468

2024

Volltextzugriff (PDF)

The risk of prostate cancer for men on aspirin, statin or antidiabetic medications

European journal of cancer (1990), 2015-04, Vol.51 (6), p.725-733

2015

Volltextzugriff (PDF)

Towards Next-generation Urine-based Prostate Cancer Risk Stratification

European urology, 2018-12, Vol.74 (6), p.739-740

2018

Volltextzugriff (PDF)

Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality

JAMA oncology, 2022-07, Vol.8 (7), p.1019

2022

Volltextzugriff (PDF)

Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy

Journal of clinical pathology, 2020-10, Vol.73 (10), p.630-635

2020

Volltextzugriff (PDF)

Association between PSA density and prostate cancer in men without significant MRI lesions

BJU international, 2020-06, Vol.125 (6), p.763-764

2020

Volltextzugriff (PDF)

Reply to Erik Rud, Peter Lauritzen, and Eduard Baco's Letter to the Editor re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol 2018;74:722–8

European urology, 2019-04, Vol.75 (4), p.e104-e105

2019

Volltextzugriff (PDF)

Reducing private car demand, fact or fiction? A study mapping changes in accessibility to grocery stores in Norway

European transport research review, 2021, Vol.13 (1), p.39-39, Article 39

2021

Volltextzugriff (PDF)

A Genetic Score Can Identify Men at High Risk for Prostate Cancer Among Men With Prostate-Specific Antigen of 1–3 ng/ml

European urology, 2014-06, Vol.65 (6), p.1184-1190

2014

Volltextzugriff (PDF)

The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort

Prostate cancer and prostatic diseases, 2019-03, Vol.22 (1), p.137-142

2019

Volltextzugriff (PDF)

Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI Study

JAMA oncology, 2023-01, Vol.9 (1), p.88

2023

Volltextzugriff (PDF)

Reply to Ola Bratt and Anna Öfverholm's Letter to the Editor re: Peter Ström, Tobias Nordström, Henrik Grönberg, Martin Eklund. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.12.028

European urology, 2018-07, Vol.74 (1), p.e10-e11

2018

Volltextzugriff (PDF)

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies

World journal of urology, 2021-04, Vol.39 (4), p.1153-1159

2021

Volltextzugriff (PDF)

Re: Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol 2015;68:139–46

European urology, 2018-08, Vol.74 (2), p.e35-e36

2018

Volltextzugriff (PDF)

Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml

Scandinavian journal of urology, 2020-01, Vol.54 (1), p.1-6

2020

Volltextzugriff (PDF)

Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors

World journal of urology, 2023-11, Vol.41 (11), p.2967-2974

2023

Volltextzugriff (PDF)

Future directions in prostate cancer testing: a comment upon results from the prospective population-based diagnostic STHLM3 study—Grönberg H et al. Lancet Oncology. 2015 Nov 9; doi:10.1016/S1470-2045(15)00361-7

World journal of urology, 2017-06, Vol.35 (6), p.895-896

2017

Volltextzugriff (PDF)

Rapid increase in multidrug-resistant enteric bacilli blood stream infection after prostate biopsy-A 10-year population-based cohort study

The Prostate, 2015-06, Vol.75 (9), p.947-956

2015

Volltextzugriff (PDF)

Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI

BMJ open, 2019-06, Vol.9 (6), p.e027816-e027816

2019

Volltextzugriff (PDF)

Improving GIS-based models for bicycling speed estimations

46th European Transport Conference, ETC 2018, Dublin, Ireland, 2019, Vol.42, p.85-99

2019

Volltextzugriff (PDF)

Intensity of Active Surveillance and Transition to Treatment in Men with Low-risk Prostate Cancer

European urology oncology, 2020-10, Vol.3 (5), p.640-647

2020

Volltextzugriff (PDF)

The STHLM3 prostate cancer diagnostic study: calibration, clarification, and comments

Nature reviews. Clinical oncology, 2016-06, Vol.13 (6), p.394-394

2016

Volltextzugriff (PDF)

Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators

European urology focus, 2021-05, Vol.7 (3), p.546-553

2021

Volltextzugriff (PDF)

Spatio-temporal variation in prostate cancer testing in Stockholm: A population-based study

PloS one, 2024-08, Vol.19 (8), p.e0308254

2024

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Aktive Filter

ThemaProstatic Neoplasms - Diagnosis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(105)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Prostate Age Gap: An MRI Surrogate Marker of Aging for Prostate Cancer Detection

The risk of prostate cancer for men on aspirin, statin or antidiabetic medications

Towards Next-generation Urine-based Prostate Cancer Risk Stratification

Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality

Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy

Association between PSA density and prostate cancer in men without significant MRI lesions

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis

Reply to Erik Rud, Peter Lauritzen, and Eduard Baco's Letter to the Editor re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol 2018;74:722–8

Reducing private car demand, fact or fiction? A study mapping changes in accessibility to grocery stores in Norway

A Genetic Score Can Identify Men at High Risk for Prostate Cancer Among Men With Prostate-Specific Antigen of 1–3 ng/ml

The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort

Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI Study

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies

Re: Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol 2015;68:139–46

Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml

Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors

Future directions in prostate cancer testing: a comment upon results from the prospective population-based diagnostic STHLM3 study—Grönberg H et al. Lancet Oncology. 2015 Nov 9; doi:10.1016/S1470-2045(15)00361-7

Rapid increase in multidrug-resistant enteric bacilli blood stream infection after prostate biopsy-A 10-year population-based cohort study

Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI

Improving GIS-based models for bicycling speed estimations

Intensity of Active Surveillance and Transition to Treatment in Men with Low-risk Prostate Cancer

The STHLM3 prostate cancer diagnostic study: calibration, clarification, and comments

Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators

Spatio-temporal variation in prostate cancer testing in Stockholm: A population-based study

Aktive Filter

Suchergebnisse filtern